Inhaltsbereich
| 105 Einträge | « ‹ 1, 2, 3, 4, 5, 6 › » |
Seite 4 / 6
 Druckansicht
|
| Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer. |
| Wenzel M, Nocera L, Ruvolo CC, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI |
| The Journal of urology. 2021 Mar 8. doi: 10.1097/JU.0000000000001695 |
| PMID: 33683934 |
| Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients. |
| Collà Ruvolo C, Stolzenbach LF, Nocera L, Deuker M, Wenzel M, Tian Z, La Rocca R, Creta M, Capece M, Saad F, Shariat SF, Tilki D, Briganti A, Mirone V, Karakiewicz PI |
| Urologia internationalis. 2021 Mar 12. pii: 000513361. doi: 10.1159/000513361 |
| PMID: 33709970 |
| Incidence rates and contemporary trends in primary urethral cancer. |
| Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Mandel P, Becker A, Kluth LA, Chun FKH, Karakiewicz PI |
| Cancer causes & control : CCC. 2021 Mar 22. doi: 10.1007/s10552-021-01416-2. pii: 10.1007/s10552-021-01416-2 |
| PMID: 33751293 |
| Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis. |
| Wenzel M, Würnschimmel C, Nocera L, Collà Ruvolo C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Roos FC, Mandel P, Chun FKH, Karakiewicz PI |
| European urology focus. 2021 Apr 11. pii: S2405-4569(21)00109-7. doi: 10.1016/j.euf.2021.04.003 |
| PMID: 33853754 |
| Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy. |
| Wenzel M, Würnschimmel C, Chierigo F, Mori K, Tian Z, Terrone C, Shariat SF, Saad F, Tilki D, Graefen M, Mandel P, Roos FC, Chun FKH, Karakiewicz PI |
| European urology focus. 2021 Apr 28. pii: S2405-4569(21)00117-6. doi: 10.1016/j.euf.2021.04.011 |
| PMID: 33933420 |
| A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer. |
| Van den Broeck T, Oprea-Lager D, Moris L, Kailavasan M, Briers E, Cornford P, De Santis M, Gandaglia G, Gillessen Sommer S, Grummet JP, Grivas N, Lam TBL, Lardas M, Liew M, Mason M, O'Hanlon S, Pecanka J, Ploussard G, Rouviere O, Schoots IG, Tilki D, van den Bergh RCN, van der Poel H, Wiegel T, Willemse PP, Yuan CY, Mottet N |
| European urology. 2021 May 4. pii: S0302-2838(21)00298-0. doi: 10.1016/j.eururo.2021.04.028 |
| PMID: 33962808 |
| Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis. |
| Lardas M, Grivas N, Debray TPA, Zattoni F, Berridge C, Cumberbatch M, Van den Broeck T, Briers E, De Santis M, Farolfi A, Fossati N, Gandaglia G, Gillessen S, O'Hanlon S, Henry A, Liew M, Mason M, Moris L, Oprea-Lager D, Ploussard G, Rouviere O, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PP, Yuan CY, Grummet JP, Tilki D, van den Bergh RCN, Lam TB, Cornford P, Mottet N |
| European urology focus. 2021 May 6. pii: S2405-4569(21)00126-7. doi: 10.1016/j.euf.2021.04.020 |
| PMID: 33967010 |
| Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis. |
| Deuker M, Krimphove MJ, Stolzenbach LF, Collà Ruvolo C, Nocera L, Mansour M, Tian Z, Roos FC, Becker A, Kluth LA, Shariat SF, Black PC, Kassouf W, Tilki D, Saad F, Chun FKH, Karakiewicz PI |
| Clinical genitourinary cancer. 2021 Apr 8. pii: S1558-7673(21)00073-2. doi: 10.1016/j.clgc.2021.03.010 |
| PMID: 33972185 |
| Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities. |
| Würnschimmel C, Wenzel M, Collà Ruvolo C, Nocera L, Tian Z, Saad F, Briganti A, Shariat SF, Mandel P, Chun FKH, Tilki D, Graefen M, Karakiewicz PI |
| World journal of urology. 2021 May 12. doi: 10.1007/s00345-021-03720-7. pii: 10.1007/s00345-021-03720-7 |
| PMID: 33978812 |
| Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups. |
| Würnschimmel C, Wenzel M, Collà Ruvolo C, Nocera L, Tian Z, Saad F, Briganti A, Shariat SF, Mirone V, Chun FK, Tilki D, Graefen M, Karakiewicz PI |
| International journal of urology : official journal of the Japanese Urological Association. 2021 May 15. doi: 10.1111/iju.14595 |
| PMID: 33993551 |
| Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy. |
| Wenzel M, Würnschimmel C, Chierigo F, Tian Z, Shariat SF, Terrone C, Saad F, Tilki D, Graefen M, Mandel P, Kluth LA, Chun FKH, Karakiewicz PI |
| The Prostate. 2021 May 19. doi: 10.1002/pros.24169 |
| PMID: 34010465 |
| Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns. |
| Würnschimmel C, Wenzel M, Chierigo F, Flammia RS, Mori K, Tian Z, Shariat SF, Saad F, Briganti A, Suardi N, Terrone C, Gallucci M, Chun FKH, Tilki D, Graefen M, Karakiewicz PI |
| The Prostate. 2021 May 31. doi: 10.1002/pros.24175 |
| PMID: 34057220 |
| Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. |
| Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI |
| Prostate cancer and prostatic diseases. 2021 May 30. doi: 10.1038/s41391-021-00395-4. pii: 10.1038/s41391-021-00395-4 |
| PMID: 34054128 |
| Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer. |
| Mori K, Sharma V, Comperat EM, Sato S, Laukhtina E, Schuettfort VM, Pradere B, Sari Motlagh R, Mostafaei H, Quhal F, Kardoust Parizi M, Abufaraj M, Karakiewicz PI, Egawa S, Tilki D, Boorjian SA, Shariat SF |
| Annals of surgical oncology. 2021 Jun 11. doi: 10.1245/s10434-021-10257-x. pii: 10.1245/s10434-021-10257-x |
| PMID: 34117577 |
| ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer? |
| Mori K, Sharma V, Egawa S, Tilki D, Boorjian SA, Shariat SF |
| Annals of surgical oncology. 2021 Jun 21. doi: 10.1245/s10434-021-10335-0. pii: 10.1245/s10434-021-10335-0 |
| PMID: 34152524 |
| Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review. |
| Moris L, Gandaglia G, Vilaseca A, Van den Broeck T, Briers E, De Santis M, Gillessen S, Grivas N, O'Hanlon S, Henry A, Lam TB, Lardas M, Mason M, Oprea-Lager D, Ploussard G, Rouviere O, Schoots IG, van der Poel H, Wiegel T, Willemse PP, Yuan CY, Grummet JP, Tilki D, van den Bergh RCN, Cornford P, Mottet N |
| European urology focus. 2021 Jun 16. pii: S2405-4569(21)00161-9. doi: 10.1016/j.euf.2021.05.009 |
| PMID: 34147405 |
| Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy. |
| Bravi CA, Droghetti M, Fossati N, Gandaglia G, Suardi N, Mazzone E, Cucchiara V, Scuderi S, Barletta F, Schiavina R, Osmonov D, Juenemann KP, Boeri L, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A |
| European urology oncology. 2021 Jun 24. pii: S2588-9311(21)00118-8. doi: 10.1016/j.euo.2021.06.003 |
| PMID: 34176768 |
| Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy. |
| Aydh A, Mori K, D'Andrea D, Motlagh RS, Abufaraj M, Pradere B, Mostafaei H, Laukhtina E, Quhal F, Karakiewicz PI, Luzzago S, Briganti A, Trinh QD, Parizi MK, Tilki D, Enikeev DV, Shariat SF |
| International journal of clinical oncology. 2021 Jun 28. doi: 10.1007/s10147-021-01952-6. pii: 10.1007/s10147-021-01952-6 |
| PMID: 34184136 |
| Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients. |
| Wenzel M, Würnschimmel C, Chierigo F, Tian Z, Shariat SF, Terrone C, Saad F, Tilki D, Graefen M, Roos FC, A Kluth L, Mandel P, Chun FKH, Karakiewicz PI |
| The Prostate. 2021 Jul 26. doi: 10.1002/pros.24202 |
| PMID: 34312910 |
| Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy. |
| Wenzel M, Würnschimmel C, Chierigo F, Flammia RS, Tian Z, Shariat SF, Gallucci M, Terrone C, Saad F, Tilki D, Graefen M, Becker A, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI |
| European urology focus. 2021 Jul 29. pii: S2405-4569(21)00188-7. doi: 10.1016/j.euf.2021.07.008 |
| PMID: 34334344 |
| 105 Einträge | « ‹ 1, 2, 3, 4, 5, 6 › » |
Seite 4 / 6
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
